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We report detection of Bartonella henselae DNA in
blood samples from 2 harbor porpoises (Phocoena pho-
coena). By using real-time polymerase chain reaction, we
directly amplified Bartonella species DNA from blood of a
harbor porpoise stranded along the northern North Carolina
coast and from a pre-enrichment blood culture from a sec-
ond harbor porpoise. The second porpoise was captured
out of habitat (in a low-salinity canal along the northern
North Carolina coast) and relocated back into the ocean.
Subsequently, DNA was amplified by conventional poly-
merase chain reaction for DNA sequencing. The 16S–23S
intergenic transcribed spacer region obtained from each
porpoise was 99.8% similar to that of B. henselae strain
San Antonio 2 (SA2), whereas both heme-binding phage-
associated  pap31 gene sequences were 100% homolo-
gous to that of B. henselae SA2. Currently, the geographic
distribution, mode of transmission, reservoir potential, and
pathogenicity of bloodborne Bartonella species in porpois-
es have not been determined.
B
artonellosis is a newly emerging worldwide zoonotic
disease (1,2) that can be caused by a spectrum of
Bartonella species. These members of the alpha subdivi-
sion of the class Proteobacteria are gram-negative aerobic
bacilli and comprise at least 20 species and subspecies.
Infection with Bartonella species causes lymphadenopathy
(3), disorders of the central nervous system (including
encephalopathy, hemiplegia, epilepsy, and subcortical
frontoparietal lesions) (4–7), bacillary angiomatosis and
bacillary peliosis (8), fever, adenitis, endocarditis (9–12),
hepatosplenic involvement, cutaneous vasculitis, and
osteomyelitis in domestic animals and humans (13–15).
Bartonella species have been isolated from numerous
domestic and wild terrestrial animals, including cats, dogs,
deer, cattle, lions, rabbits, and rodents (16–20). Because
Bartonella spp. frequently induce persistent intravascular
infections, particularly in reservoir hosts, attributing dis-
ease causation to Bartonella infection in animals or in
human patients has been difficult, and satisfying Koch
postulates for disease causation remains challenging (21).
Because conventional microbiologic techniques lack
sensitivity, bartonellosis is usually diagnosed by using
polymerase chain reaction amplification of organism-spe-
cific DNA sequences or serologic testing (1,22–25).
Recently, a more sensitive isolation approach was devel-
oped by using Bartonella alpha Proteobacteria growth
medium (BAPGM) followed by real-time polymerase
chain reaction (PCR). This method has greatly facilitated
the molecular detection or isolation of Bartonella species
from the blood of sick and healthy animals (24). The rela-
tive sensitivity of diagnostic methods used to detect
Bartonella species infection greatly influences the ability
to establish disease causation. The use of these optimized
microbiologic techniques facilitated the recognition of
bloodborne  Bartonella  spp. infections in porpoises, as
reported in this study. 
We report real-time PCR detection of B. henselae SA2
DNA in porpoise blood samples. Harbor porpoises are
cetaceans in the family Phocoenidae that are found alone
or in small groups in coastal waters, bays, and estuaries in
cold, temperate, and subarctic waters of the Northern
Hemisphere (26). In the western Atlantic, they range from
Baffin Island and Labrador in the north, extending as far
south as North Carolina in the winter. Initially, blood sam-
ples were screened by using real-time PCR targeting the
Bartonella henselae in 
Porpoise Blood 
Ricardo G. Maggi,* Craig A. Harms,*† Aleta A. Hohn,‡ D. Ann Pabst,§ William A. McLellan,§ 
Wendy J. Walton,¶ David S. Rotstein,# and Edward B. Breitschwerdt*
*North Carolina State University College of Veterinary Medicine,
Raleigh, North Carolina, USA; †Center for Marine Sciences and
Technology, Morehead City, North Carolina, USA: ‡National
Marine Fisheries Service, Beaufort, North Carolina, USA;
§University of North Carolina Wilmington, Wilmington, North
Carolina, USA; ¶Virginia Aquarium and Marine Science Center,
Virginia Beach, Virginia, USA; and #University of Tennessee
College of Veterinary Medicine, Knoxville, Tennessee, USABartonella 16S–23S RNA intergenic spacer (ITS) region,
or the heme-binding phage-associated gene pap31 (27).
Preenrichment liquid BAPGM blood cultures were also
screened by real-time PCR, after which conventional PCR
was used to obtain DNA for sequencing and identifying
Bartonella species to the strain level. 
Materials and Methods
Sample Testing
Blood samples (anticoagulated with EDTA) were
obtained from a live, stranded yearling female harbor por-
poise (Phocoena phocoena) that required humane killing
in northern North Carolina in May 2005 (MLC 001) and
from a yearling male harbor porpoise. The male porpoise
was captured out of habitat (in a low-salinity canal [3 parts
salt per 1,000; by comparison, sea water contains 36 parts
per 1,000] along the northern North Carolina coast) and
relocated to the ocean in March 2005 (AAH 009). The
samples were analyzed as follows. Following DNAextrac-
tion, real-time PCR (using DNA probes) and conventional
PCR were used to screen for Bartonella DNA in each
blood sample (23). A preenrichment culture was estab-
lished from the original sample by using liquid BAPGM
(24). After a 7-day incubation period, a sample was
removed from the culture flask for conventional PCR and
real-time PCR. In addition, sheep blood (used as blood
supplement for preenrichment culture) and a sheep blood
preenrichment BAPGM culture were screened for
Bartonella DNAas a negative control at the time each por-
poise sample was processed. Bartonella DNA was not
detected in any control samples. 
Growth Medium
Preenrichment culture of EDTA-anticoagulated blood
samples from the 2 porpoises tested in this study was per-
formed as follows. A 1-mL aliquot of blood was added to
10 mL of BAPGM and incubated at 35°C in a 5% CO2,
water-saturated atmosphere as previously described (24).
DNA Extraction and PCR Screening 
of Blood and Blood Cultures
Screening for Bartonella species DNA was conducted
by using conventional PCR and real-time PCR directly
with EDTA-anticoagulated blood and from the 7-day
postenrichment BAPGM blood culture samples. Gene
sequencing was used to establish the species and strain
classification. DNA was prepared by using the DNA Mini
Kit (Qiagen, Valencia, CA, USA) from 200 µL of the
blood sample and from 200 µL of preenrichment blood
culture in BAPGM medium. After extraction, DNA con-
centration and quality were measured by using an
absorbance ratio at 260:280 nm.
Real-Time PCR Analysis 
Real-time PCR screening for Bartonella species was
performed as described previously (23). Scorpion 321 flu-
orescent probe 5′-FAM-CCG CGT TTT TCA AAG CCC
ACG CGG-QUE-HEG-AGA TGA TGA TCC CAA GCC
TTC TGG-3′ and oligonucleotide 425as 5′-GGA TRA
AYYRGWAAACCTTYM YCG G-3′ were used as sense
and antisense primers, respectively, for screening of the
Bartonella  genus-specific ITS region. Identification of
Bartonella species was conducted by using real-time mul-
tiplex PCR with species-specific fluorescent probes
(Taqman, Appled Biosystems, Foster City, CA, USA) in
conjunction with oligonucleotides 321s 5′-AGA TGA
TGATCC CAAGCC TTC TGG CG-3′ and 421as 5′-GGA
TRA AYY RGW AAA CCT TYM YCG G-3′ as forward
and reverse primers (Integrated DNA Technologies,
Coralville, IA, USA), respectively. The species-specific
fluorescent probe sequences (Taqman) used were 5′-FAM-
CCA CCG TGG GCT TTG AAA AAC GCT-3′ DBHQ1
for B. henselae, 5′-TexRed-GGG ACT TTA AGG AAG
ACA CTT TTG TG-BHQ2-3′ for B. quintana, 5′-ROX-
TGC ACA AGC CTC TGA GAG GGA TGA ANG A-
BHQ2-3′ for B. clarridgeiae, and Cy3 5′-CTT TCY TGT
AAG AGT GTA TTT TTT ATC TAA GA-BHQ2-3′ for B.
vinsonii  subspecies  berkhoffii. Real-time reactions were
performed by using a SmartCycler II System (Cepheid,
Sunnyvale, CA, USA) in 25-µL reaction volumes as
described previously (23). Negative controls were pre-
pared by using DNA extracted from sheep blood samples
(the same used as blood supplement in BAPG liquid medi-
um). PCR positive controls contained DNA from sheep
blood samples spiked with B. clarridgeiae (ATCC 700095;
American Type Culture Collection, Manassas, VA, USA),
Bartonella henselae Houston-1 (ATCC 49882), B. quin-
tana Fuller (ATCC VR-358), or B. vinsonii subsp. berkhof-
fii (ATCC 51672) DNA to a final concentration of 10
fg/µL. Real-time PCR conditions were a single hot-start
cycle at 95°C for 30 s, followed by 55 cycles of denaturing
at 94°C for 10 s, annealing at 58°C for 6 s (for Bartonella)
or at 60°C for 6 sec (for the 4 Bartonella species), and final
extension at 72°C for 10 s. Positive amplicons were detect-
ed by reading fluorescence at the appropriate wavelength.
Conventional PCR Analysis
ITS Region
PCR screening of the Bartonella 16S–23S ITS region
was performed on samples that were positive by real-time
PCR, as described (24),when amplicon size allows prelim-
inary species identification. Oligonucleotides 321s 5′-
AGA TGA TGA TCC CAA GCC TTC TGG-3′ and 983as
5′-TGT TCTYAC AAC AAT GAT GAT G-3′ were used as
forward and reverse primers, respectively. The ITS region
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8.5 µL of molecular grade water (Epicentre, Madison, WI,
USA) 0.5 µL 10 mmol/L dNTP mixture, 2.5 µL of 10×
PCR buffer, 2.5 µL of 25 mmol/L MgCl2, and 0.7 units of
Amplitaq Gold DNA polymerase (Applied Biosystems).
The reaction mixture was completed by adding 0.25 µLo f
30 µmol/L of each forward and reverse primer (Integrated
DNA Technologies) and 10 µL of DNA from each sample
tested. PCR negative controls contained 10 µL of DNA
extracted from BAPGM (when testing BAPGM cultures)
or 10 µL of DNA extracted from sheep blood (when test-
ing blood samples). Conventional PCR conditions were a
single hot-start cycle at 95°C for 5 min, followed by 45
cycles of denaturing at 94°C for 45 s, annealing at 54°C for
45 s, and extension at 72°C for 45 s. Amplification was
completed by an additional cycle at 72°C for 5 min.
Products were analyzed by electrophoresis on 2% agarose
gels and detected by staining with ethidium bromide and
viewing under UV light. Amplicon products were
sequenced to identify species strains. 
pap31 Gene Amplification
PCR species screening was performed by using primers
designed to amplify a consensus sequence of the phage-
associated gene pap31 found in several species of the
Bartonella  genus (27). Oligonucleotides Pap31 1(s) 5′-
GAC TTC TGT TAT CGC TTT GAT TT-3′ and Pap31 688
(as) 5′-CAC CAC CAG CAA MAT AAG GCA T-3′ were
used as forward and reverse primers, respectively.
Amplification of the pap31 gene was performed in a 25-
µL final volume reaction as described above. PCR condi-
tions for pap31 gene amplification were a single hot-start
cycle at 95°C for 5 min, followed by 45 cycles of denatur-
ing at 94°C for 45 s, annealing at 58°C for 45 s, and exten-
sion at 72°C for 45 s. Amplification was completed by an
additional cycle at 72°C for 5 min. Products were analyzed
by electrophoresis on 2% agarose gels and detected by
staining with ethidium bromide and viewing under UV
light. Amplicons were sequenced to identify specific
strains. 
Cloning and Sequencing of ITS 
and pap31 Gene Amplicons
Bartonella ITS and pap31 DNA sequencing was per-
formed for 2 positive amplicons for both the ITS and
pap31 gene to confirm the Bartonella species and strain.
The amplified PCR products were cloned into the Plasmid
pGEM-T Easy Vector System (Promega, Madison, WI,
USA). Recombinants (white colonies) were selected on the
basis of the right size of the insert in the plasmid using a
plasmid miniprep procedure (Qiagen). Sequencing of plas-
mid inserts was done by Davis Sequencing, Inc. (Davis,
CA, USA). Sequence analysis and alignment with
GenBank sequences were performed by using AlignX soft-
ware (Vector NTI Suite 6.0, InforMax, Inc., Frederick,
MD, USA) to identify bacteria at species and strain level.
Results
Blood and Preenrichment Blood Culture Real-Time PCR
Following direct extraction from blood, Bartonella
DNAwas amplified from 1 (MLC 001) of the 2 porpoises.
Real-time PCR amplification of Bartonella DNAwas pos-
sible from the harbor porpoise stranded along the North
Carolina coast, but not from the porpoise (AAH 009) that
was captured and released until after the 7-day BAPGM
enrichment period. Using a multiplex real-time PCR assay
developed in the Vector-Borne Disease Diagnostic
Laboratory at North Carolina State University, we identi-
fied B. henselae as the infecting species in both porpoises.
Bartonella vinsonii subsp. berkhoffii, B. clarridgeae, and
B. quintana DNAwas not detected by using real-time PCR
species-specific probes, which suggests that these species
were not present in the original blood samples or in the
preenrichment cultures. Bartonella DNA was not detected
by real-time PCR in samples extracted from the sheep
blood used as a negative control before and after preen-
richment culture.
Cloning and Sequencing
The Bartonella species was confirmed by cloning and
sequencing the 16S–23S ITS region and the pap31 gene.
The ITS and pap31 DNA sequences from both porpoises
were consistent with that of B. henselae strain San Antonio
2 (GenBank accession no. AF369529). The 16S–23S ITS
sequence matches were 675/677 bp (99.7%) for MLC 001
and 676/677 bp (99.8%) for AAH 009. The ITS sequence
from MLC 001 contained 2 bp insertions (a C and a T), at
positions 45 and 675, respectively, when compared with
the ITS GenBank sequences for B. henselae SA2.
Sequences from AAH 009 contained only a C insertion at
position 45. The pap31 gene sequences derived from both
porpoises matched 540/540 bp (100%) with B. henselae
SA2 (GenBank accession no. AF308168). 
Discussion
We report the first detection of a Bartonella species
from the blood of a cetacean, the detection of B. henselae
from a nonterrestrial animal. This study was initiated by a
request to use molecular diagnostic to evaluate blood from
a stranded sick porpoise and from a porpoise captured out
of its natural habitat. 
MLC 001, a yearling female that was stranded in a
remote location, may have been stranded for many hours
before it could safely be reached and humanely killed.
There was no evidence of fisheries interaction. The animal
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was thin, and necropsy showed no food in its stomach.
Few obvious gross lesions and parasites were noted. The
degree of postmortem autolysis was more than would be
expected in a freshly killed animal. This finding, with
signs of cranial epaxial and caudal abdominal muscle hem-
orrhages and the friable condition of the muscle, suggests
that the animal’s condition likely deteriorated during
stranding. Results of histopathologic examination were
unremarkable and lesions known to be consistent with bar-
tonellosis were not found. 
AAH 009, found swimming in a low-salinity canal, had
2 lacerations (2.5 and 5 cm long) over the left dorsal trunk
cranial to the dorsal fin, 1 of which extended the full thick-
ness through the blubber, but was not bleeding. In addition,
≈8 clusters of pinpoint lesions were observed slightly cra-
nial and dorsal to the lacerations, which may have been due
to punctures or viral skin lesions. Assessment of the por-
poise’s behavior, body condition, and hematologic param-
eters indicated that it was not debilitated despite its unusual
location. It was then tagged and released into the ocean.
Molecular evidence of Bartonella infection was obtained
by direct PCR on whole blood from MLC 001, and by
using a recently improved diagnostic method that com-
bines preenrichment blood culture (24) and real-time PCR
in samples from AAH 009. An isolate was not obtained
from either porpoise after application of the preenrichment
BAPGM blood culture onto a blood agar plate. 
Recently, various emerging or reemerging infectious
diseases or infections of serious epizootic or zoonotic
potential have been described in marine mammals (28–32).
These include morbillivirus infection, brucellosis, toxo-
plasmosis, sarcocystosis, papillomavirus infection, and
West Nile virus infection (29,31,33). As was the case for
brucellosis, recognized as an emerging disease in a marine
mammal in 1994 (34,35), bartonellosis may become an
important emerging marine mammal infectious disease.
Current evidence indicates that all known Bartonella
species are vector transmitted, with bites or scratches (cat
scratch disease) providing an alternative means of trans-
mission for B. henselae (2,20). The B. henselae SA2
sequence deposited in GenBank was amplified from an
isolate derived from a human lymph node aspiration sam-
ple (9). Although exposed to rose thorns and cats, the
patient did not recall an animal bite or scratch, and illness
developed after a recent tick bite, which was attributed to
Amblyomma americanum, based on the location and time
of the year. Since the mode of infection was not estab-
lished in these porpoises, the potential role of trauma, as
induced by tooth raking, or transmission by biting marine
invertebrates should be investigated. 
As for many fastidious pathogens, difficulties associat-
ed with Bartonella detection and isolation have compro-
mised efforts to define the role of these organisms in
disease causation. Enhancement of organism-specific
DNA detection and isolation through the use of an opti-
mized isolation medium such as BAPGM can aid in eval-
uating serodiagnostic assays and may advance
understanding the diversity, adaptation, and epidemiology
of this genus (24,36). Based on the recent use of BAPGM
in the North Carolina State University Vector-Borne
Disease Diagnostic Laboratory, we believe that chronic
infection with Bartonella species can contribute to subtle
clinical abnormalities or vague symptoms in companion
and wild animals or in humans. 
Angiomatosis, an important pathologic manifestation
of Bartonella infection in immunocompromised persons
(8,21),has been previously reported in bottlenose dolphins
(37). Since angiomatous lesions are unusual pathologic
lesions and B. henselae is a recently recognized cause of
vasoproliferative lesions in humans (8,15), examination of
angiomatous lesions from cetaceans for the presence of B.
henselae should be a priority in future studies. In addition,
the involvement of Bartonella species in disorders of the
central nervous system and neurologic dysfunction in ani-
mals and humans (4–7)suggests that this genus should be
considered in stranding events. Although Bartonella infec-
tion in the vasculature of reservoir hosts is generally not
accompanied by pathologic changes, Bartonella spp. may
become pathogenic in combination with severe stress, mal-
nutrition, increased exposure to toxins, and concurrent
infection with other organisms. PCR amplification direct-
ly from an extracted blood sample or from a preenrichment
blood culture showed that both porpoises in this study
were infected with B. henselae SA2. Since infection with
Bartonella spp. has been documented in a marine mam-
mal, the clinical impact, mode of transmission, pathology,
and epidemiology are areas for additional inquiry.
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